Fingerprint
Dive into the research topics of 'Efficacy and safety of eliapixant in refractory chronic cough: the randomized, placebo-controlled phase 2b PAGANINI study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and safety of eliapixant in refractory chronic cough: the randomized, placebo-controlled phase 2b PAGANINI study
Peter V Dicpinigaitis, Alyn H Morice, Jaclyn A Smith, Mandel R Sher, Michael Vaezi, Laurent Guilleminault, Akio Niimi, Kerstin Gude, Ulrike Krahn, Riitta Saarinen, Philippe Vieira Pires, Melanie Wosnitza, Lorcan McGarvey
Research output: Contribution to journal › Article › peer-review
18
Citations
(Scopus)